loadpatents
name:-0.016824007034302
name:-0.0139000415802
name:-0.0062909126281738
Von Andrian; Ulrich H. Patent Filings

Von Andrian; Ulrich H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Von Andrian; Ulrich H..The latest application filed is for "delivery of biomolecules to immune cells".

Company Profile
8.14.15
  • Von Andrian; Ulrich H. - Chestnut Hill MA
  • Von Andrian; Ulrich H. - Cambridge MA
  • von Andrian; Ulrich H. - Brookline MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Delivery Of Biomolecules To Immune Cells
App 20220064584 - Sharei; Armon R. ;   et al.
2022-03-03
Uses Of Modified Rna Encoding Retinaldehyde Dehydrogenase
App 20210338709 - Von Andrian; Ulrich H. ;   et al.
2021-11-04
Delivery of biomolecules to immune cells
Grant 11,111,472 - Sharei , et al. September 7, 2
2021-09-07
Methods And Composition For Modulating Immune Response And Immune Homeostasis
App 20210118522 - Ziegler; Carly G.K. ;   et al.
2021-04-22
Vaccine nanotechnology
Grant 10,736,848 - Von Andrian , et al. A
2020-08-11
Vaccine Nanotechnology
App 20200054559 - von Andrian; Ulrich H. ;   et al.
2020-02-20
Microvessel endothelial cell surface markers and uses thereof
Grant 10,307,487 - von Andrian , et al.
2019-06-04
Venule endothelial cell genes and uses thereof
Grant 10,206,941 - von Andrian , et al. Feb
2019-02-19
Vaccines comprising bisphosphonate and methods of use thereof
Grant 10,188,733 - von Andrian , et al. Ja
2019-01-29
Delivery Of Biomolecules To Immune Cells
App 20180142198 - SHAREI; Armon R. ;   et al.
2018-05-24
Vaccine nanotechnology
Grant 9,539,210 - von Andrian , et al. January 10, 2
2017-01-10
Vaccine nanotechnology
Grant 9,526,702 - von Andrian , et al. December 27, 2
2016-12-27
Endothelial Cell Genes And Uses Thereof
App 20160354403 - von Andrian; Ulrich H. ;   et al.
2016-12-08
Vaccine nanotechnology
Grant 9,474,717 - von Andrian , et al. October 25, 2
2016-10-25
Targeting of antigen presenting cells with immunonanotherapeutics
Grant 9,308,280 - Shi , et al. April 12, 2
2016-04-12
Vaccine Nanotechnology
App 20140314865 - von Andrian; Ulrich H. ;   et al.
2014-10-23
Targeting of Antigen Presenting Cells With Immunonanotherapeutics
App 20140037736 - Shi; Jinjun ;   et al.
2014-02-06
Vaccines Comprising Bisphosphonate And Methods Of Use Thereof
App 20130309270 - von Andrian; Ulrich H. ;   et al.
2013-11-21
Vaccine Nanotechnology
App 20130287857 - von Andrian; Ulrich H. ;   et al.
2013-10-31
Methods for the treatment of multiple myeloma
Grant 8,569,280 - von Andrian , et al. October 29, 2
2013-10-29
Vaccine Nanotechnology
App 20130236533 - von Andrian; Ulrich H. ;   et al.
2013-09-12
Methods For The Treatment Of Multiple Myeloma
App 20110070244 - von Andrian; Ulrich H. ;   et al.
2011-03-24
Methods for the treatment of multiple myeloma
Grant 7,825,088 - von Andrian , et al. November 2, 2
2010-11-02
Vaccine Nanotechnology
App 20100233251 - Von Andrian; Ulrich H. ;   et al.
2010-09-16
Methods for the treatment of multiple myeloma
App 20070003558 - von Andrian; Ulrich H. ;   et al.
2007-01-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed